Amelioration of elastase-induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice

19Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background and Purpose: Chronic obstructive pulmonary disease, encompassing chronic airway obstruction and lung emphysema, is a major worldwide health problem and a severe socio-economic burden. Evidence previously provided by our group has shown that inhibition of inducible NOS (iNOS) prevents development of mild emphysema in a mouse model of chronic tobacco smoke exposure and can even trigger lung regeneration. Moreover, we could demonstrate that pulmonary hypertension is not only abolished in cigarette smoke-exposed iNOS−/− mice but also precedes emphysema development. Possible regenerative effects of pharmacological iNOS inhibition in more severe models of emphysema not dependent on tobacco smoke, however, are hitherto unknown. Experimental Approach: We have established a mouse model using a single dose of porcine pancreatic elastase or saline, intratracheally instilled in C57BL/6J mice. Emphysema, as well as pulmonary hypertension development was determined by both structural and functional measurements. Key Results: Our data revealed that (i) emphysema is fully established after 21 days, with the same degree of emphysema after 21 and 28 days post instillation, (ii) emphysema is stable for at least 12 weeks and (iii) pulmonary hypertension is evident, in contrast to smoke models, only after emphysema development. Oral treatment with the iNOS inhibitor N(6)-(1-iminoethyl)-l-lysine (L-NIL) was started after emphysema establishment and continued for 12 weeks. This resulted in significant lung regeneration, evident in the improvement of emphysema and reversal of pulmonary hypertension. Conclusion and Implications: Our data indicate that iNOS is a potential new therapeutic target to treat severe emphysema and associated pulmonary hypertension. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc.

References Powered by Scopus

Simultaneous inference in general parametric models

10348Citations
N/AReaders
Get full text

Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide

6945Citations
N/AReaders
Get full text

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

3203Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Nitric Oxide System and Bronchial Epithelium: More Than a Barrier

40Citations
N/AReaders
Get full text

Cigarette smoke induces the ROS accumulation and iNOS activation through deactivation of Nrf-2/SIRT3 axis to mediate the human bronchial epithelium ferroptosis

32Citations
N/AReaders
Get full text

Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema

12Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Fysikopoulos, A., Seimetz, M., Hadzic, S., Knoepp, F., Wu, C. Y., Malkmus, K., … Kraut, S. (2021). Amelioration of elastase-induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice. British Journal of Pharmacology, 178(1), 152–171. https://doi.org/10.1111/bph.15057

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

62%

Researcher 4

31%

Professor / Associate Prof. 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

69%

Biochemistry, Genetics and Molecular Bi... 2

15%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Social Sciences 1

8%

Save time finding and organizing research with Mendeley

Sign up for free